RJFSA
IHE icon

Raymond James Financial Services Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Raymond James Financial Services Advisors’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.11M Sell
15,650
-15,762
-50% -$1.1M ﹤0.01% 2096
2024
Q2 		$2.08M Buy
31,412
+17,529
+126% +$1.15M ﹤0.01% 1642
2024
Q1 		$943K Sell
13,883
-35,371
-72% -$2.34M ﹤0.01% 2106
2023
Q4 		$3.04M Buy
49,254
+37,989
+337% +$2.23M ﹤0.01% 1346
2023
Q3 		$665K Sell
11,265
-78
-0.7% -$4.79K ﹤0.01% 2149
2023
Q2 		$677K Sell
11,343
-1,398
-11% -$83.1K ﹤0.01% 2160
2023
Q1 		$744K Sell
12,741
-3,498
-22% -$211K ﹤0.01% 2097
2022
Q4 		$1.01M Sell
16,239
-999
-6% -$60.1K ﹤0.01% 1834
2022
Q3 		$975K Buy
17,238
+189
+1% +$11.6K ﹤0.01% 1827
2022
Q2 		$1.09M Buy
17,049
+6,387
+60% +$406K ﹤0.01% 1781
2022
Q1 		$691K Sell
10,662
-192
-2% -$12.2K ﹤0.01% 2182
2021
Q4 		$723K Buy
10,854
+441
+4% +$28K ﹤0.01% 2158
2021
Q3 		$636K Sell
10,413
-639
-6% -$40.6K ﹤0.01% 2216
2021
Q2 		$685K Sell
11,052
-597
-5% -$36.3K ﹤0.01% 2174
2021
Q1 		$690K Buy
11,649
+792
+7% +$47.8K ﹤0.01% 2081
2020
Q4 		$650K Sell
10,857
-30
-0.3% -$1.71K ﹤0.01% 1975
2020
Q3 		$594K Sell
10,887
-285
-3% -$15.4K ﹤0.01% 1869
2020
Q2 		$573K Sell
11,172
-753
-6% -$37.9K ﹤0.01% 1824
2020
Q1 		$535K Sell
11,925
-138
-1% -$6.96K ﹤0.01% 1507
2019
Q4 		$644K Sell
12,063
-729
-6% -$35.9K ﹤0.01% 1811
2019
Q3 		$596K Sell
12,792
-2,697
-17% -$129K ﹤0.01% 1789
2019
Q2 		$779K Buy
15,489
+54
+0.3% +$2.67K ﹤0.01% 1643
2019
Q1 		$792K Sell
15,435
-2,013
-12% -$100K ﹤0.01% 1595
2018
Q4 		$819K Sell
17,448
-11,271
-39% -$578K ﹤0.01% 1373
2018
Q3 		$1.61M Buy
28,719
+8,421
+41% +$460K 0.01% 1200
2018
Q2 		$1.02M Sell
20,298
-981
-5% -$48.6K 0.01% 1410
2018
Q1 		$1.05M Sell
21,279
-2,817
-12% -$145K 0.01% 1274
2017
Q4 		$1.24M Buy
24,096
+1,749
+8% +$89.9K 0.01% 1172
2017
Q3 		$1.17M Sell
22,347
-507
-2% -$26K 0.01% 1213
2017
Q2 		$1.18M Buy
22,854
+2,493
+12% +$126K 0.01% 1162
2017
Q1 		$1.02M Sell
20,361
-873
-4% -$43.2K 0.01% 1166
2016
Q4 		$1M Buy
21,234
+5,022
+31% +$238K 0.01% 1113
2016
Q3 		$807K Sell
16,212
-4,299
-21% -$218K 0.01% 1217
2016
Q2 		$987K Sell
20,511
-14,022
-41% -$667K 0.01% 1052
2016
Q1 		$1.58M Sell
34,533
-106,575
-76% -$4.99M 0.02% 726
2015
Q4 		$7.61M Buy
141,108
+69,186
+96% +$3.64M 0.09% 275
2015
Q3 		$3.55M Buy
+71,922
New +$4.12M 0.06% 365
2015
Q2 		– Sell
-154,059
Closed -$8.85M – 695
2015
Q1 		$8.85M Sell
154,059
-28,605
-16% -$1.56M 0.43% 49
2014
Q4 		$9.22M Buy
182,664
+1,887
+1% +$91.9K 0.48% 47
2014
Q3 		$8.46M Sell
180,777
-1,359
-0.7% -$61.3K 0.46% 50
2014
Q2 		$8.2M Buy
182,136
+6
+0% +$258 0.49% 48
2014
Q1 		$7.69M Buy
182,130
+1,650
+0.9% +$69.2K 0.45% 55
2013
Q4 		$7.11M Sell
180,480
-2,295
-1% -$86.1K 0.44% 59
2013
Q3 		$6.48M Buy
182,775
+140,262
+330% +$4.94M 0.43% 59
2013
Q2 		$1.41M Buy
+42,513
New +$1.41M 0.04% 498

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RW
Rockport Wealth Fairview Park, Ohio $549M AUM 22.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Raymond James Financial Services Advisors's IHE Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its iShares US Pharmaceuticals ETF (IHE) stake by 50% in Q3 2024, selling an estimated $1.1M and leaving 15,650 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

Raymond James Financial Services Advisors first reported a position in IHE in Q2 2013 and has held it in 45 quarters since. The position peaked at $9.22M in Q4 2014. 143 funds tracked by Wall St. Rank hold IHE as of Q3 2024.

  • Raymond James Financial Services Advisors held 15,650 shares of iShares US Pharmaceuticals ETF worth $1.11M as of Q3 2024.
  • Raymond James Financial Services Advisors sold 15,762 iShares US Pharmaceuticals ETF shares in Q3 2024, an estimated $1.1M.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2096 holding.
  • Raymond James Financial Services Advisors first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 45 quarters since.
  • Raymond James Financial Services Advisors's iShares US Pharmaceuticals ETF position peaked at $9.22M in Q4 2014.
  • 143 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.